Enzyme-linked immunosorbent assays using novel Japanese encephalitis virus antigen improve the accuracy of clinical diagnosis of flavivirus infections

Clinical and Vaccine Immunology

Volumn 15, Issue 5, 2008, Pages 825-835

  Chiou, Shyan Song ^a   Crill, Wayne D ^b   Chen, Li Kuang ^c   Chang, Gwong Jen J ^b,d  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c TZU CHI UNIVERSITY   (Taiwan)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; JAPANESE ENCEPHALITIS VIRUS ANTIGEN; MONOCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS PROTEIN; VIRUS PROTEIN E; IMMUNOGLOBULIN M; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; JAPANESE ENCEPHALITIS VIRUS; MAXIMUM LIKELIHOOD METHOD; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT PLASMID; SERODIAGNOSIS; STATISTICAL ANALYSIS; VIRUS DIAGNOSIS; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS LIKE AGENT; VIRUS MUTANT; VIRUS RECOMBINANT; VIRUS STRAIN; WILD TYPE; ANIMAL; BLOOD; CELL STRAIN COS1; CERCOPITHECUS; CLASSIFICATION; FLAVIVIRUS; HAMSTER; IMMUNOLOGY; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CERCOPITHECUS AETHIOPS; COS CELLS; CRICETINAE; CROSS REACTIONS; ENCEPHALITIS VIRUS, JAPANESE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; HUMANS; IMMUNOGLOBULIN M; VIRAL ENVELOPE PROTEINS;

EID: 46249085517     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00004-08     Document Type: Article

References (41)

1. Allison, S. L., J. Schalich, K. Stiasny, C. W. Mandl, and F. X. Heinz. 2001. Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J. Virol. 75:4268-4275.
2. Beasley, D. W., M. R. Holbrook, A. P. Travassos Da Rosa, L. Coffey, A. S. Carrara, K. Phillippi-Falkenstein, R. P. Bohm, Jr., M. S. Ratterree, K. M. Lillibridge, G. V. Ludwig, J. Estrada-Franco, S. C. Weaver, R. B. Tesh, R. E. Shope, and A. D. Barrett. 2004. Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection. J. Clin. Microbiol. 42:2759-2765.
3. Blok, J., S. Samuel, A. J. Gibbs, and U. T. Vitarana. 1989. Variation of the nucleotide and encoded amino acid sequences of the envelope gene from eight dengue-2 viruses. Arch. Virol. 105:39-53.
4. Chang, G. J., B. S. Davis, C. Stringfield, and C. Lutz. 2007. Prospective immunization of the endangered California condors (Gymnogyps californianus) protects this species from lethal West Nile virus infection. Vaccine 25:2325-2330.
5. Chang, G. J., A. R. Hunt, and B. Davis. 2000. A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice. J. Virol. 74:4244-4252.
6. Crill, W. D., and G. J. Chang. 2004. Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J. Virol. 78:13975-13986.
7. Crill, W. D., N. B. Trainor, and G. J. Chang. 2007. A detailed mutagenesis study of flavivirus cross-reactive epitopes using West Nile virus-like particles. J. Gen. Virol. 88:1169-1174.
8. Davis, B. S., G. J. Chang, B. Cropp, J. T. Roehrig, D. A. Martin, C. J. Mitchell, R. Bowen, and M. L. Bunning. 2001. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J. Virol. 75:4040-4047.
9. Gentry, M. K., E. A. Henchal, J. M. McCown, W. E. Brandt, and J. M. Dalrymple. 1982. Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies. Am. J. Trop. Med. Hyg. 31:548-555.
10. Halstead, S. B. 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239:476-481.
11. Hanley, J. A., and B. J. McNeil. 1983. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148:839-843.
12. Hawkes, R. A., J. T. Roehrig, C. R. Boughton, H. M. Naim, R. Orwell, and P. Anderson-Stuart. 1990. Defined epitope blocking with Murray Valley encephalitis virus and monoclonal antibodies: laboratory and field studies. J. Med. Virol. 32:31-38.
13. Holmes, D. A., D. E. Purdy, D. Y. Chao, A. J. Noga, and G. J. Chang. 2005. Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections. J. Clin. Microbiol. 43:3227-3236.
14. Hunt, A. R., C. B. Cropp, and G. J. Chang. 2001. A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen. J. Virol. Methods 97:133-149.
15. Innis, B. L., A. Nisalak, S. Nimmannitya, S. Kusalerdchariya, V. Chongswasdi, S. Suntayakorn, P. Puttisri, and C. H. Hoke. 1989. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am. J. Trop. Med. Hyg. 40:418-427.
16. Kanai, R., K. Kar, K. Anthony, L. H. Gould, M. Ledizet, E. Fikrig, W. A. Marasco, R. A. Koski, and Y. Modis. 2006. Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes. J. Virol. 80:11000-11008.
17. Kimura-Kuroda, J., and K. Yasui. 1986. Antigenic comparison of envelope protein E between Japanese encephalitis virus and some other flaviviruses using monoclonal antibodies. J. Gen. Virol. 67:2663-2672.
18. Kimura-Kuroda, J., and K. Yasui. 1983. Topographical analysis of antigenic determinants on envelope glycoprotein V3 (E) of Japanese encephalitis virus, using monoclonal antibodies. J. Virol. 45:124-132.
19. Kitai, Y., M. Shoda, T. Kondo, and E. Konishi. 2007. Epitope-blocking enzyme-linked immunosorbent assay to differentiate West Nile virus from Japanese encephalitis virus infections in equine sera. Clin. Vaccine Immunol. 14:1024-1031.
20. Kuno, G. 2003. Serodiagnosis of flaviviral infections and vaccinations in humans. Adv. Virus Res. 61:3-65.
21. Kuno, G., H. Artsob, N. Karabatsos, K. R. Tsuchiya, and G. J. Chang. 2001. Genomic sequencing of deer tick virus and phylogeny of powassan-related viruses of North America. Am. J. Trop. Med. Hyg. 65:671-676.
22. Lanciotti, R. S., J. T. Roehrig, V. Deubel, J. Smith, M. Parker, K. Steele, B. Crise, K. E. Volpe, M. B. Crabtree, J. H. Scherret, R. A. Hall, J. S. MacKenzie, C. B. Cropp, B. Panigrahy, E. Ostlund, B. Schmitt, M. Malkinson, C. Banet, J. Weissman, N. Komar, H. M. Savage, W. Stone, T. McNamara, and D. J. Gubler. 1999. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286:2333-2337.
23. Mackenzie, J. S. 2005. Emerging zoonotic encephalitis viruses: lessons from Southeast Asia and Oceania. J. Neurovirol. 11:434-440.
24. Mackenzie, J. S., D. J. Gubler, and L. R. Petersen. 2004. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10:S98-S109.
25. Martin, D. A., B. J. Biggerstaff, B. Allen, A. J. Johnson, R. S. Lanciotti, and J. T. Roehrig. 2002. Use of immunoglobulin M cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin. Diagn. Lab. Immunol. 9:544-549.
26. Nitayaphan, S., J. A. Grant, G. J. Chang, and D. W. Trent. 1990. Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2. Virology 177:541-552.
27. Oliphant, T., G. E. Nybakken, M. Engle, Q. Xu, C. A. Nelson, S. Sukupolvi-Petty, A. Marri, B. E. Lachmi, U. Olshevsky, D. H. Fremont, T. C. Pierson, and M. S. Diamond. 2006. Antibody recognition and neutralization determinants on domains I and II of West Nile virus envelope protein. J. Virol. 80:12149-12159.
28. Purdy, D. E., A. J. Noga, and G. J. Chang. 2004. Noninfectious recombinant antigen for detection of St. Louis encephalitis virus-specific antibodies in serum by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 42:4709-4717.
29. Rey, F. A., F. X. Heinz, C. Mandl, C. Kunz, and S. C. Harrison. 1995. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375:291-298.
30. Roberson, J. A., W. D. Crill, and G. J. Chang. 2007. Differentiation of West Nile and St. Louis encephalitis virus infections using cross-reactivity reduced noninfectious virus-like particles. J. Clin. Microbiol. 45:3167-3174.
31. Roehrig, J. T., R. A. Bolin, and R. G. Kelly. 1998. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 246:317-328.
32. Roehrig, J. T., A. R. Hunt, A. J. Johnson, and R. A. Hawkes. 1989. Synthetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley encephalitis virus elicit antiviral antibody. Virology 171:49-60.
33. Roehrig, J. T., A. J. Johnson, A. R. Hunt, R. A. Bolin, and M. C. Chu. 1990. Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation. Virology 177:668-675.
34. Roehrig, J. T., J. H. Mathews, and D. W. Trent. 1983. Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Virology 128:118-126.
35. Shu, P. Y., S. F. Chang, Y. C. Kuo, Y. Y. Yueh, L. J. Chien, C. L. Sue, T. H. Lin, and J. H. Huang. 2003. Development of group- and serotype-specific one-step SYBR green I-based real-time reverse transcription-PCR assay for dengue virus. J. Clin. Microbiol. 41:2408-2416.
36. Shu, P. Y., L. K. Chen, S. F. Chang, Y. Y. Yueh, L. Chow, L. J. Chien, C. Chin, T. H. Lin, and J. H. Huang. 2003. Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections. Clin. Diagn. Lab. Immunol. 10:622-630.
37. Stiasny, K., S. Kiermayr, H. Holzmann, and F. X. Heinz. 2006. Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J. Virol. 80:9557-9568.
38. Sukupolvi-Petty, S., S. K. Austin, W. E. Purtha, T. Oliphant, G. E. Nybakken, J. J. Schlesinger, J. T. Roehrig, G. D. Gromowski, A. D. Barrett, D. H. Fremont, and M. S. Diamond. 2007. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J. Virol. 81:12816-12826.
39. Trainor, N. B., W. D. Crill, J. A. Roberson, and G. J. Chang. 2007. Mutation analysis of the fusion domain region of St. Louis encephalitis virus envelope protein. Virology 360:398-406.
40. Vaughn, D. W., and C. H. Hoke, Jr. 1992. The epidemiology of Japanese encephalitis: prospects for prevention. Epidemiol. Rev. 14:197-221.
41. Wu, Y. C., Y. S. Huang, L. J. Chien, T. L. Lin, Y. Y. Yueh, W. L. Tseng, K. J. Chang, and G. R. Wang. 1999. The epidemiology of Japanese encephalitis on Taiwan during 1966-1997. Am. J. Trop. Med. Hyg. 61:78-84.